Net Cash Provided by (Used in) Investing Activities of Emmaus Life Sciences, Inc. from 30 Sep 2010 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
Emmaus Life Sciences, Inc. annual and quarterly Net Cash Provided by (Used in) Investing Activities in USD history and change rate from 30 Sep 2010 to 31 Dec 2024.
  • Emmaus Life Sciences, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending 31 Mar 2024 was $4,000, a 100% increase year-over-year.
  • Emmaus Life Sciences, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2024 was $2,500,000.
  • Emmaus Life Sciences, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was $432,000, a 82% increase from 2022.
  • Emmaus Life Sciences, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was $2,387,000, a 63% increase from 2021.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Change (%)

Emmaus Life Sciences, Inc. Annual Net Cash Provided by (Used in) Investing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $2,500,000 +$2,932,000 01 Jan 2024 31 Dec 2024 10-K 14 Apr 2025 2024 FY
2023 $432,000 +$1,955,000 +82% 01 Jan 2023 31 Dec 2023 10-K 14 Apr 2025 2024 FY
2022 $2,387,000 +$3,990,000 +63% 01 Jan 2022 31 Dec 2022 10-K 03 Jul 2024 2023 FY
2021 $6,377,000 -$11,847,000 -217% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
2020 $5,470,000 +$6,954,000 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
2019 $1,484,000 +$5,956,000 +80% 01 Jan 2019 31 Dec 2019 10-K/A 10 Aug 2021 2020 FY
2018 $7,440,000 -$6,960,500 -1452% 01 Jan 2018 31 Dec 2018 10-K 25 Jan 2021 2019 FY
2017 $479,500 -$397,200 -483% 01 Oct 2016 30 Sep 2017 10-K 11 Dec 2018 2018 FY
2016 $82,300 01 Oct 2015 30 Sep 2016 10-K 29 Dec 2017 2017 FY
2014 $0 -$1,400 -100% 01 Oct 2013 30 Sep 2014 10-K 29 Dec 2014 2014 FY
2013 $1,400 +$26,900 01 Oct 2012 30 Sep 2013 10-K 29 Dec 2014 2014 FY
2012 $25,500 -$3,900 -18% 01 Oct 2011 30 Sep 2012 10-K 23 Dec 2013 2013 FY
2011 $21,600 -$6,700 -45% 01 Oct 2010 30 Sep 2011 10-K 15 Jan 2013 2012 FY
2010 $14,900 01 Oct 2009 30 Sep 2010 10-K 22 Dec 2011 2011 FY

Emmaus Life Sciences, Inc. Quarterly Net Cash Provided by (Used in) Investing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $4,000 +$1,087,000 +100% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q1 2023 $1,091,000 -$2,318,000 -189% 01 Jan 2023 31 Mar 2023 10-Q 10 Sep 2024 2024 Q1
Q1 2022 $1,227,000 +$2,996,000 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q1 2021 $1,769,000 -$1,766,000 -58867% 01 Jan 2021 31 Mar 2021 10-Q 13 May 2022 2022 Q1
Q1 2020 $3,000 +$13,000 +81% 01 Jan 2020 31 Mar 2020 10-Q 01 Sep 2021 2021 Q1
Q1 2019 $16,000 01 Jan 2019 31 Mar 2019 10-Q 26 Aug 2021 2020 Q1
Q4 2018 $4,100 +$330,600 +99% 01 Oct 2018 31 Dec 2018 10-Q 14 Feb 2019 2019 Q1
Q4 2017 $334,700 -$331,000 -8946% 01 Oct 2017 31 Dec 2017 10-Q 14 Feb 2019 2019 Q1
Q4 2016 $3,700 01 Oct 2016 31 Dec 2016 10-Q 20 Feb 2018 2018 Q1
Q4 2013 $0 -$1,400 -100% 01 Oct 2013 31 Dec 2013 10-Q 13 Feb 2014 2014 Q1
Q4 2012 $1,400 +$24,500 01 Oct 2012 31 Dec 2012 10-Q 13 Feb 2014 2014 Q1
Q4 2011 $23,100 -$7,200 -45% 01 Oct 2011 31 Dec 2011 10-Q/A 22 Feb 2013 2013 Q1
Q4 2010 $15,900 01 Oct 2010 31 Dec 2010 10-Q 14 Feb 2012 2012 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.